We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Bio-Rad Introduces new Pro-Human Diabetes Assay Panel

Read time: Less than a minute

Bio-Rad Laboratories, Inc. has announced new Bio-Plex Pro™ Human Diabetes Assay Panels for Bio-Rad’s Bio-Plex® suspension array system.

Offered as one multiplex and two singleplex assays designed to achieve optimal working assay ranges, the new pro-human diabetes assay can deliver accurate and reproducible multiplex measurements of human diabetes and obesity markers, the company claims.

Product Features:

• The pro-human assay panel consists of a premixed 12-plex of analytes (C-Peptide, ghrelin, GIP, and visfatin) thataGLP-1, glucagon, IL6, insulin, leptin, PAi-1, resistin, TNF- work with magnetic beads, pre-blended detection antibodies, standards and controls. The singleplex assays (adiponectin and adipsin) may be mixed together to form a 2-plex assay.

• The reagent kit includes an assay buffer, wash buffer, streptavidin-PE, 96-well filter plate, sealing tape, and panel specific instructions required to prepare assays and acquire data.

• The diluents kit can enable the researcher to choose the appropriate diluents kit for diluting samples, standards and controls.

All three Bio-Plex pro-human diabetes assays were validated using real patient samples.